- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · May 5, 2025 | 136.95M sh |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $1.32B |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $1.15B |
| Stockholders Equity | Q1 2025 · Mar 31, 2025 | $2.29B |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | $2.22B |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $1.99B |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $2.07B |
| Current Assets | Q1 2025 · Mar 31, 2025 | $3.64B |
| Current Assets | Q1 2025 · Dec 31, 2024 | $3.66B |
| Total Assets | Q1 2025 · Dec 31, 2024 | $4.75B |
| Total Assets | Q1 2025 · Mar 31, 2024 | $4.49B |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 144.13M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $360.52M |
| Capex | Q1 2025 · Mar 31, 2024 | $10.18M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $256.9M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $1.17 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $1.18 |
| Net Income | Q1 2025 · Mar 31, 2024 | $169.15M |
| Operating Income | Q1 2025 · Mar 31, 2024 | $214.78M |
| Revenue | Q1 2025 · Mar 31, 2024 | $2.21B |